Background: During pressure overload-induced hypertrophy, unloading-induced atrophy, and diabetes mellitus, the heart induces 'fetal' genes (e.g. myosin heavy chain β; mhcβ).
Introduction
The heart adapts to changes in its physiologic environment, initially through alterations in the activity state and/or locality of pre-existing proteins within the cardiomyocyte. Chronic activation of intracellular signaling cascades affect the levels of specifi c proteins in the cell, through transcriptional, translational and post-translational mechanisms. For example, increased workload acutely increases glycogenolysis, glucose transport, and lactate oxidation, with a lesser effect on fatty acid oxidation (Goodwin et al. 1998) . Persistence of pressure overload on the heart results in sustained alterations in metabolism as a consequence of changes in the expression of proteins involved in glucose and fatty acid utilization (Allard et al. 1994) .
Sustained pressure overload not only affects substrate preference, but also leads to a remodeling of the heart. Cardiomyocytes increase in size (hypertrophy), together with alterations in the expression of multiple myocardial genes (Kleinman et al. 1978; Sugden and Clerk, 1998) . In the latter case, the hypertrophied heart reverts to a fetal pattern of gene expression, wherein various fetal genes are induced with a concomitant repression of adult genes (Komuro and Yazaki, 1993; Depre et al. 1998) . One example is the switching of mhc isoforms, in which mhcβ (the fetal isoform) is induced, while mhcα (the adult isoform) is repressed in the hypertrophied rat heart (Depre et al. 1998; Mercadier et al. 1981) .
The exact mechanism(s) by which this isoform switching occurs is (are) not known. It is an intriguing observation that sustained decreases in work load or sustained changes in the metabolic milieu (e.g. insulin defi cient diabetes mellitus) induce a similar patter of isoform switching (Depre et al. 1998; Dillmann, 1980; Depre et al. 2000) .
The purpose of the present study was to explore the hypothesis that substrate metabolism and/or intracellular metabolites are responsible for mhc isoform switching in the heart in response to stimuli such as pressure overload. More specifically, we hypothesized that accumulation of intramyocellular glucose metabolites drives mhc isoform switching in the hypertrophied heart. This hypothesis was investigated by: 1) increasing glucose infl ux into the heart ex vivo; 2) increasing glucose infl ux into the heart in vivo; 3) attenuating increased glucose infl ux by the heart during pressure overload-induced hypertrophy in vivo; and 4) investigating potential glucose sensing components in both the normal and pressure overloaded heart. The results are consistent with the notion that alterations in glucose metabolism play a role in mhc isoform switching.
Methods

Animals and dietary interventions
Rats: Male Spraque-Dawley rats were kept in the Animal Care Center of the University of TexasHouston Medical School. Mice: Male wild-type and MHCα-GLUT1 transgenic littermates with cardiac-specifi c overexpression of GLUT1 were kept in the Animal Resource Facility at Harvard Medical School. All rodents were housed under controlled conditions (23 ± 1 o C; 12 h light/12 h dark cycle) and received chow and water ad libitum. The investigations conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) .
Rodents were fed one of three isocaloric diets; standard laboratory chow (Purina), a high carbohydrate/low fat diet (HC/LF; Research Diets Inc., New Brunswick, NJ), or a low carbohydrate/ high fat diet (LC/HF; Research Diets Inc., New Brunswick, NJ). Because the latter two diets were isocaloric, they varied only in the proportion of energy obtained from carbohydrate and fat. For the rat studies, the contribution of carbohydrate, fat and protein to total energy available were 71%, 6% and 23% for the HC/LF diet, and 24%, 53% and 23% for the LC/HF diet, respectively. For the mouse studies, the contribution of carbohydrate, fat and protein to total energy available were 70%, 10% and 20% for the HC/LF diet, and 20%, 60% and 20% for the LC/HF diet, respectively. The fat component consisted chiefl y of lard (saturated, long-chain fatty acids). All other animals were fed the standard laboratory chow.
Working heart ex vivo
Isolated rat hearts were perfused for 90 min in the working mode (15 cm H 2 O preload/100 cm H 2 O afterload) with Krebs-Henseleit buffer containing β-hydroxybutyrate (10 mM), acetoacetate (1 mM) and propionyl-L-carnitine (2 mM). In certain experiments, glucose (25 mM) was added to the perfusate. Mannitol (25 mM) was added to the perfusate when glucose was absent. A physiologic concentration of insulin (40 µU/ml; Lilly) was included in all perfusions. At the end, hearts were freeze-clamped and stored in liquid nitrogen. This method has been described in detail elsewhere (Taegtmeyer et al. 1980 ).
Ascending aortic constriction in vivo
Cardiac pressure overload was induced by constriction of the ascending aorta (Kleinman et al. 1978) . In control animals, sham operations were performed. During the seven days before surgery, the animals received either standard laboratory chow (control diet), the HC/LF diet, or the LC/HF diet. Specifi c feeding was maintained until the completion of the experiment (i.e. isolation of hearts), either nine days (HC/LF and LC/HF feeding studies) or seven weeks (standard laboratory chow studies) after surgery. The effects of banding and altered dietary fat content on body weight and heart weight are shown in Table 1 .
RNA isolation and quantitative RT-PCR
RNA extraction and quantitative RT-PCR of samples was performed using previously described methods (Depre et al. 1998; Chomczynski and Sacchi 1987; Gibson et al. 1996) . Specifi c quantitative assays were designed for mhcα, mhcβ, gfat1, gfat2, glucose 6-phosphate dehydrogenase (g6pdh), and transketolase (tkl ) using rat and mouse sequences available in GenBank (Table 2 ). Primers and probes were designed from non-conserved sequences of the genes (allowing for isoform specifi city), spanning sites where two exons join (splice sites), preventing recognition of the assay to any potential contaminating genomic DNA. Standard RNA was made for all assays by the T7 polymerase method (Ambion, Austin, Texas), using total RNA isolated from rat hearts. The correlation between the C t (the number of PCR cycles required for the fl uorescent signal to reach a detection threshold) and the amount of standard was linear over at least a 5-log range of RNA for all assays (data not shown). PCR data are reported as the number of mRNA transcripts per ng total RNA.
UDP-N-Acetylglucosamine
The levels of UDP-N-acetylglucosamine, the major end product of the hexosamine biosynthetic pathway, were measured in perchloric acid extracts of rat heart homogenates using highperformance liquid chromatography and spectrophotometry as previously described (Veerababu et al. 2000) .
Xylulose 5-Phosphate
Myocardial levels of the pentose phosphate pathway (PPP) intermediate xylulose 5-phosphate were measured using a spectrophotometric assay similar to that described previously for the liver (Casazza and Veech, 1986) . Briefl y, deproteinized heart samples were prepared by homogenizing approximately 400 mg of powdered heart with 5.6% perchloric acid (2 mls). Following neutrilization, xylulose 5-phosphate levels were measured in PCA extracts by following NADH generation via the combined transketolase and glyceraldehyde 3-phosphate dehydrogenase reactions. 
Gene Primer/Probe Sequence
mhcα Forward 5′-TGAAAAGATTAACCGGAGTTTAAGA-3′ Reverse 5′-CAGGCACGAAGCACTCTGTG-3′ Probe 5′-FAM-CCIAAGTCAGCCATCTGGGCATC-TAMRA-3′ mhcβ Forward 5′-TCCTCCCTCAAGCTCCTAAGTAA-3′ Reverse 5′-TTTGCCTTTGCCCTTGTCTA-3′ Probe 5′-FAM-CATCAGCICCAGCATAGTTGGCAAACA-TAMRA-3′ gfat1 Forward 5′-GCCGAGCTGTGCAAACTCT-3′ Reverse 5′-GGCTGCTCAAAAATTTCCTTC-3′ Probe 5-′FAM-CTCCAGCAGATCATGAAGGGCAACTTTAGT-TAMRA-3′ gfat2 Forward 5′-GCCAGTTCATCTCTCTGGTGC-3′ Reverse 5′-ATCTGAGGCCACGGATGAT-3′ Probe 5′-FAM-TGGTTTGATGATGTCTGAAGATCGAATTTCTC-TAMRA-3′ g6pdh Forward 5′-GGGCAAAGAGATGGTCCAG-3′ Reverse 5′-TCGATTCCAGATGGGTCCA-3′ Probe 5′-FAM-AGATCCTGTTGGCAAATCTCAGCACCA-TAMRA-3′ tkl Forward 5′-CGAAACCCTCACAATGATCG-3′ Reverse 5′-AGCTTCAGCCCAGACTGCA-3′ Probe 5′-FAM-TTTGTGCTCTCCAAGGGCCATGC-TAMRA-3′
Statistical analysis
Data are presented as the mean ± SEM for between four and ten hearts in each group. Statistically signifi cant differences between groups were calculated by analysis of variance (ANOVA). A value of p Ͻ 0.05 was considered signifi cant.
Results
Glucose induces mhc isoform switching ex vivo
To determine whether glucose induced mhc isoform switching in hearts under controlled conditions ex vivo, the isolated working rat heart preparation was utilized. Working rat hearts from animals fed a standard laboratory chow diet were perfused either in the absence or presence of glucose (25 mM). In the former case, mannitol (25 mM) was added to the perfusate to allow for any osmotic effects of glucose on heart function and/or gene expression. A trend for lower levels of mhcα mRNA was observed for hearts perfused in the presence of glucose compared to those perfused in the presence of mannitol, although this did not reach statistical signifi cance (Fig. 1A) . However, mhcβ mRNA levels were signifi cantly elevated in hearts perfused with glucose, compared to those perfused with mannitol (Fig. 1B) . The mhcα/mhcβ ratio (a marker of isoform switching) was signifi cantly lower in glucose-perfused hearts (Fig. 1C) .
Glucose induces mhc isoform switching in vivo
To investigate whether glucose induced mhc isoform switching occurs in vivo, we utilized mice with a cardiomyocyte-specifi c overexpression of the glucose transporter GLUT1; hearts from these mice, which have been characterized previously (Luptak et al. 2007 ), do not exhibit contractile dysfunction. Hearts isolated from transgenic mice fed the HC/LF diet exhibit signifi cantly lower mhcα expression, with a concomitant greater mhcβ expression, compared to hearts isolated from wild-type littermates, fed the same diet ( Figs. 2A-2B ). Feeding mice the LC/HF diet prevented this isoform switching; mhcα expression was not signifi cantly different between wildtype and transgenic mice fed the LC/HF diet, whereas mhcβ was signifi cantly lower in hearts isolated from transgenic versus wild-type mice fed the LC/HF diet (Fig. 2B ). As such, mhc isoform switching (mhcα/mhcβ ratio) observed for hearts isolated from transgenic mice was prevented when mice were fed the LC/HF diet (Fig. 2C ). Effects of glucose on mhcα (A) and mhcβ (B) expression, as well as the mhcα/mhcβ ratio (C), in the perfused working rat heart. Hearts were perfused for 90 minutes in Krebs-Henseleit buffer containing β-hydroxybutyrate (10 mM), acetoacetate (1 mM), propionyl-Lcarnitine (2 mM) and insulin (40 µUnits/ml), without (control) or with glucose (25 mM). Control hearts were also perfused in the presence of mannitol (25 mM). Values are shown as the mean ±S.E.M. for four separate observations. *, p Ͻ 0.05.
Limiting dietary carbohydrate availability prevents mhc isoform switching in response to pressure overload
We have shown before that nine days of aortic constriction induces left ventricular hypertrophy in rats fed either HC/LF or LC/HF diet (i.e. dietindependent); diet alone had no effects on body weight, or heart weight (Young et al. 2001b) . The same was the case in the present study (Table 1) .
Aortic constriction of animals placed on the HC/LF diet resulted in decreased mhcα mRNA levels (Fig. 3A) , and a concomitant increase in mhcβ mRNA levels (Fig. 3B ). This isoform switching was not observed in response to pressure overload when rats were placed on the LC/HF diet (Figs. 3A-3B). Diet alone had no effects on MHC isoform expression in the heart (Figs. 3A-3B, black columns). As such, pressure overloadinduced mhc isoform switching (as indicated by the mhcα/mhcβ ratio) was prevented when rats were fed the LC/HF diet (Fig. 3C) . We also measured transcript levels of the "fetal" genes basic fi broblast growth factor (bfgf) and skeletal α-actin (sk α-actin) (Figs. 3D-3E ). Like the transcript levels of MHCβ, pressure overload-mediated induction of these two transcripts was attenuated when rats were fed the LC/HF diet.
Sustained pressure overload activates the hexosamine biosynthetic pathway
To investigate whether increased fl ux through the hexosamine biosynthetic pathway occurs in response to pressure overload in the heart, we measured: 1) the expression of two isoforms of GFAT (glutamine fructose 6-phosphate amidotransferase, gfat1 and gfat2) which catalyzes the fl ux generating step in this pathway; and 2) UDP-Nacetylglucosamine, the principal end-product of this pathway, in control as well as in hypertrophied hearts (Veerababu et al. 2000; Yki-Jarvinen et al. 1998; Rossetti et al. 1995) .
Ascending aortic constriction for seven weeks induced hypertrophy (heart-to-body weight ratios 2.84 ± 0.02 vs 3.69 ± 0.05, control vs banded; p Ͻ 0.001). The level of gfat1 expression was not signifi cantly different between the control and hypertrophic hearts (Fig. 4A ). In contrast, the level of gfat2 mRNA was 38% higher in pressure overloaded hearts compared to control hearts (Fig. 4B ). In addition, pressure overload was also associated with a 40% increase in cardiac UDP-N-acetylglucosamine levels (Fig. 4C ).
No effect of sustained pressure overload on the pentose phosphate pathway
To investigate whether increased fl ux through the pentose phosphate pathway occurs in response to pressure overload in the heart, seven weeks after aortic constriction we measured in control and hypertrophied hearts: 1) the expression of two key enzymes in xylulose 5-phosphate biosynthesis, namely g6pdh (glucose 6-phosphate dehydrogenase) and tkl (transketolase); and 2) xylulose 5-phosphate, an important regulatory intermediate in this pathway. The results indicate that neither the expression of g6pdh nor tkl were affected by sustained pressure overload (Figs. 4D-4E ). Xylulose 5-phosphate levels were also not different (Fig. 4F ).
Discussion
We provide strong evidence in support of the hypothesis that glucose metabolites play a role in the adaptation of the myocardium to pressure overload, at the level of gene expression. When hearts are forced to utilize glucose, both ex vivo (glucose perfused hearts) and in vivo (GLUT1 transgenic mice), mhc isoform switching is induced. Limiting dietary glucose prevents mhc isoform switching in both GLUT1 transgenic hearts and pressure overload-induced hypertrophied hearts. For potential mechanisms we focused on the hexosamine biosynthetic pathway and the pentose phosphate pathway (Fig. 5) . Myocardial levels of gfat2 mRNA (encoding for a fl ux generating enzyme in the hexosamine biosynthetic pathway) and UDP-Nacetylglucosamine (the major end-product of this pathway) were elevated in response to pressure overload. In contrast, no alterations in the expression of two key enzymes in the pentose phosphate pathway (namely g6pdh and tkl) were observed in the hypertrophied heart, nor was there an increase in xylulose 5-phosphate levels.
Glucose sensing in the heart
A hallmark of long-term adaptation of the rodent heart to environmental stresses is the re-expression of a fetal gene program. The predominant isoform of myosin heavy chain (mhc) expressed in the fetal heart of the rodent is mhcβ. During the fi rst weeks of post-natal life, mhcβ declines and is replaced by the adult isoform, mhcα (Schwartz et al. 1992 ). In the presence of chronic stimuli, including pressure overload, mechanical unloading or diabetes, the heart re-expresses mhcβ with concomitant repression of mhcα expression (Depre et al. 1998; Mercadier et al. 1981) . To date, no single pathway has been attributed to this isoform switching in the heart to these various stimuli.
We propose a unifying hypothesis that is based on the following reasoning. Despite the apparent opposing metabolic adaptation of the heart to alterations in workload and a diabetic milieu, we propose that glycolytic intermediates accumulate in the heart during both situations due to an imbalance between glucose uptake and phosphorylation on the one hand and pyruvate oxidation on the other hand (Fig. 5 ). In the hypertrophied heart (and the atrophied and fetal hearts), glucose uptake and metabolism are both increased (Allard et al. 1994; Doenst et al. 2001 ). However, the high rate of glucose uptake exceeds the rate of pyruvate oxidation, resulting in accumulation of glycolytic intermediates. A similar scenario may occur for the heart during hypoxia, where decreased expression of peroxisome proliferator-activated receptor α-(PPARα-) regulated genes is associated with increased reliance on glucose (Razeghi et al. 2001) . We designed the experiments with the assumption that with LC/HF we signifi cantly reduced carbohydrate availability, although neither blood glucose nor insulin levels were measured. Previously published studies have shown lower plasma glucose and insulin levels in the fed state for rats fed a high fat (low carbohydrate) diet (De Gasquet et al. 1977 ). This pattern is markedly different from insulindependent diabetes mellitus, where both glucose and fatty acids levels are markedly elevated. In contrast to the hypertrophied heart, the diabetic heart increases reliance on fatty acids as a fuel. Fatty acids inhibit glucose oxidation at the level of the pyruvate dehydrogenase complex (PDC) to a greater extent than they inhibit glucose uptake. Increased mitochondrial acetyl-CoA and NADH levels (due to increased fatty acid and ketone body utilization) and phosphorylation by PDC kinase 4 (due to PPARα-mediated induction) jointly inhibit PDC (Wu et al. 1999; Randle et al. 1978) . Despite decreased glucose transporter expression and decreased insulin-mediated glucose transport, the rates of glucose uptake in the diabetic environment, are comparable to those observed in normal hearts, due to the prevailing hyperglycemia (Ungar et al. 1955 ). Thus, with normal glucose infl ux into the cardiomyocyte, and the block at PDC, glucose metabolites accumulate. Indeed, intracellular concentrations of glucose, glucose 6-phosphate, fructose 6-phosphate, glycogen, pyruvate and lactate have all been shown to be increased in the heart during diabetes (Chen et al. 1984; Stroedter et al. 1995) . Additional evidence exists in support of the hypothesis. If the rate of glucose oxidation is increased in the pressure overloaded heart, thereby re-coupling glycolysis and pyruvate oxidation, through treatment of rats with etomoxir, an irreversible inhibitor of carnitine palmitoyltransferase I, mhc isoform switching is attenuated (Turcani and Rupp, 1997) . Similar results are observed for the heart in diabetes. Myocardial mhc isoform switching during diabetes is prevented by treatment with etomoxir, as well as a second fatty acid oxidation inhibitor, methylpalmoxirate (Dillmann, 1985; Rupp et al. 1994) . It therefore appears that whenever there is a loss of coupling between glycolysis and pyruvate oxidation, either due to increased glucose infl ux (e.g. fetal, hypertrophied and atrophied hearts) and/or inhibition of pyruvate oxidation (e.g. heart in diabetes), mhc isoform switching occurs. Glucose sensing may be the common mechanism. In addition to the mhc isoforms, the expression of various other genes is altered in the above situations. For example, skeletal α-actin is induced during pressure overload, an effect that is abolished when substrate switching is prevented (Young et al. 2001a) (Fig. 3E) Figure 5. Hypothetical mechanism of glucose sensing in the heart in response to hemodynamic or metabolic stress. A loss of synchronization between glucose infl ux into the cardiomyocyte and pyruvate oxidation during pressure overload results in accumulation of glyoclytic intermediates. The latter can cause an increased fl ux through the pentose phosphate pathway (via G6PDH or TKL) and the hexosamine biosynthethic pathway (via GFAT), resulting in accumulation in xylulose 5-phosphate and UDP N-acetyl glucosamine, respectively. These metabolites affect the activity of various enzymes and transcription factors for phosphorylation and/or glycosylation events.
induction of skeletal α-actin during pressure overload is dependent on the activation of Sp1, a transcription factor that is known to be activated in response to increased glucose availability in liver (Karns et al. 1995) . More recently the nuclear receptor LXR has been identifi ed as a glucose sensor in the lever as well (Mitro et al. 2007) . In this tissue, LXR serves as a switch for the integration of various metabolic pathways. While fatty acids are able to modulate gene expression in the heart, most likely through activation of the nuclear receptor PPARα, (Barger and Kelly, 2000) nothing is known concerning glucoseregulated gene expression in the heart. Extensive work in liver suggests the involvement of two major pathways in the sensing of glucose availability, namely the hexosamine biosynthetic pathway and the pentose phosphate pathway (Girard et al. 1997; Ferré 1999; Vaulont et al. 2000) . The present studies provide evidence that glucose sensing occurs in the heart.
Hexosamine biosynthetic pathway
Increased infl ux of glucose into the cell, and/or increased activity of GFAT, results in increased fl ux through the hexosamine biosynthetic pathway (Hebert, Jr., et al. 1996) . The resultant elevation in the principal end-product of this pathway, UDP-N-acetylglucosamine, is utilized by transferases for the O-linked glycosylation of various target proteins (Wells et al. 2001) . Such O-linked glycosylation of signaling proteins occurs at serine and threonine residues otherwise utilized as regulatory phosphorylation sites, a mechanism similar to phosphorylation in that it is a reversible covalent modifi cation that affects the activity of the target protein (Wells et al. 2001) . However, unlike phosphorylation, the rate of O-linked glycosylation is dependent on intracellular levels of the linkage group donor (i.e. UDP-N-acetylglucosamine, which in turn is dependent upon the infl ux of glucose into the cell, and/or increased activity of GFAT).
Proteins known to be activated by O-linked glycosylation include the transcription factors c-myc and Sp1, both of which are activated during pressure overload (Karns et al. 1995; Wells et al. 2001; Izumo et al. 1988) . O-glycosylation of Sp1 is already known for quite some time (Jackson and Tjian, 1988 ). The present study shows that UDP-N-acetylglucosamine levels were significantly elevated in pressure overloaded hearts (Fig. 4C) .
It is reasonable to assume that this increase is due to both increased expression of gfat2 (Fig. 4B) , as well as increased infl ux of glucose into the cell. We speculate that c-myc and/or Sp1 activation in the heart during pressure overload may be due, at least in part, to increased O-linked glycosylation. Thus, altered glucose metabolism would contribute toward early molecular events involved in remodeling of the heart during pressure overload and the return to the fetal gene program (Sugden and Clerk, 1998; Komuro and Yazaki, 1993; Depre et al. 1998; Mercardier et al. 1981; Dillmann, 1980; Depre et al. 2000) .
Pentose phosphate pathway
We have previously shown appreciable fl ux through the non-oxidative branch of the PPP in the heart . However, neither the expression of key enzymes involved in this pathway (g6pdh and tkl), nor the levels of xylulose 5-phosphate, were altered in the heart after seven weeks of pressure overload (Figs. 4D-4F ). This suggests that the pentose phosphate pathway may not play a major role in adaptation of the heart to sustained pressure overload. Still, this pathway may be important for acute adaptation to stimuli such as ischemia, when glycolytic intermediates accumulate rapidly. It is certainly important in the liver, where the signaling molecule xylulose 5-phospthate triggers rapid changes in the nuclear import of the transcription factor carbohydrate response element binding protein (ChREBP) which coordinates the transcriptional regulation of metabolic enzymes (Uyeda and Repa, 2006) . The role of ChREBP in the heart remains unknown.
Conclusions
We have found evidence in support of the hypothesis that alterations in metabolism are involved in the adaptation of the heart to environmental stresses, such as pressure overload, at least at the level of gene expression. Increased O-linked glycosylation of proteins may play signifi cant roles in the adaptation of the heart, in addition to transcriptional alterations, such as translational initiation (through eIF-2) or post-translational modulation of enzymatic activity (e.g. glycogen synthase) or cellular signaling (e.g. insulin signaling) (Datta et al. 1989; Crook et al. 1995; Patti et al. 1999) . Glucose sensing may therefore play a role in the adaptation of the myocardium to various stimuli, whether they are hemodynamic (e.g. increased workload) or metabolic (e.g. diabetes).
